Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Retatrutide is a peptide that mimics three hormones in the body: GLP-1, GIP, and glucagon Your gut releases GLP-1 after you eat, and it helps you feel full, slows how quickly food leaves your stomach, tells your pancreas to release insulin when blood sugar is high, and reduces how much sugar your liver releases into your blood
Another NAM analog-based NNMT inhibitor, 6-methoxy NAM (also known as JBSNF000088), has shown promise in decreasing body weight and enhancing insulin sensitivity in mice models of obesity induced by a high-fat diet 198
Availability: Which peptide is the most readily accessible through multiple channels
Your practitioner may decide to keep you at a lower maintenance dosage
On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world
Maida V, Shi RB, Fazzari FGT, Zomparelli L
US$ 26.02
US$ 23.40
US$ 29.19
US$ 28.04
US$ 22.82
US$ 21.57
